搜索临床试验以:Rekombinant humaniseret monoklonalt antistof MIL62-injektion
总计180个结果
-
Beijing Mabworks Biotech Co., Ltd.完全的CD20-positive B Cell Non-Hodgkin Lymphoma中国
-
Beijing InnoCare Pharma Tech Co., Ltd.主动,不招人
-
CARsgen Therapeutics Co., Ltd.Shanghai East Hospital主动,不招人
-
Genor Biopharma Co., Ltd.Hutchison Medipharma Limited未知
-
Shanghai Junshi Bioscience Co., Ltd.Sponsor GmbH招聘中
-
Shanghai Junshi Bioscience Co., Ltd.Sponsor GmbH招聘中
-
Shanghai Henlius BiotechHengenix Biotech Inc; Sanyou Biopharmaceuticals(Shanghai)Co., Ltd; Shanghai ZJ Bio-Tech Co., Ltd撤销
-
Peking University Cancer Hospital & Institute招聘中
-
Shandong New Time Pharmaceutical Co., LTD未知
-
Peking University Cancer Hospital & Institute主动,不招人
-
Luye Pharma Group Ltd.Shang Dong Boan Biotechnology Co., Ltd (Co-sponsor)招聘中
-
Synermore Biologics (Suzhou) Co., Ltd.完全的
-
Dragonboat Biopharmaceutical Company LimitedWest China Hospital招聘中
-
Sunshine Guojian Pharmaceutical (Shanghai) Co.,...招聘中
-
Lanzhou Institute of Biological Products Co., Ltd招聘中
-
Shanghai Henlius Biotech尚未招聘
-
Huabo Biopharm Co., Ltd.First Affiliated Hospital Bengbu Medical College招聘中
-
Shanghai Junshi Bioscience Co., Ltd.未知
-
Genor Biopharma Co., Ltd.招聘中